A carbamoyl fluoride-enabled enantioselective Ni-catalyzed carbocarbamoylation of unactivated alkenes was developed, providing a broad range of chiral γ-lactams bearing an all-carbon quaternary center in 45−96% yield and 38−97% ee.
Enantioselective Ni-catalyzed C(sp 3 )À H bond activation remains an elusive challenge. Herein, we used phosphine oxide-ligated NiÀ Al bimetallic catalyst to realize enantioselective Ni-catalyzed aliphatic C(sp 3 )À H activation of formamides, providing a series of chiral Ncontaining heterocycles in 40-95 % yield and 70-95 % ee.
A bifunctional secondary phosphine oxide (SPO) ligand-controlled method was developed for Ni−Al-catalyzed nonchelated dual C−H annulation of arylformamides with alkynes, providing a series of substituted amide-containing heterocycles in ≤97% yield. The SPO-bound bimetallic catalysis proved to be critical to the reaction efficiency.
Compared
with the widely explored exo-selective
C–H cyclization, transition metal-catalyzed endo-selective C–H cyclization of benzimidazoles with alkenes
has been a formidable challenge. Previous efforts mainly rely on substrate-controlled
methods, rendering the product complexity restricted. Herein we report
a catalyst-controlled method to facilitate endo-cyclization,
in which a bulky N-heterocyclic carbene ligand and
t
BuOK base-enabled Ni–Al bimetallic
catalyst prove critical to the endo selectivity.
Enantioselective Ni-catalyzed C(sp 3 )À H bond activation remains an elusive challenge. Herein, we used phosphine oxide-ligated NiÀ Al bimetallic catalyst to realize enantioselective Ni-catalyzed aliphatic C(sp 3 )À H activation of formamides, providing a series of chiral Ncontaining heterocycles in 40-95 % yield and 70-95 % ee.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.